Cargando…
Serum oestradiol levels and risk of adverse cardiovascular events associated with gender-affirming oestrogen therapy: a protocol for a systematic review and meta-analysis
INTRODUCTION: The use of gender-affirming oestrogen therapy (GAOT) is an integral part of the gender-affirming transition process for transgender women (assigned male at birth who identify as women) and gender-diverse individuals. However, its use may present significant cardiovascular implications,...
Autores principales: | Rytz, Chantal L, Turino Miranda, Keila, Ronksley, Paul E, Dumanski, Sandra M, Saad, Nathalie, Raj, Satish R, Somayaji, Ranjani, Ganshorn, Heather, Newbert, Amelia M, Peace, Lindsay, Ahmed, Sofia B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639097/ https://www.ncbi.nlm.nih.gov/pubmed/36328386 http://dx.doi.org/10.1136/bmjopen-2022-064961 |
Ejemplares similares
-
Response to paper by Douxfils et al. Oestradiol is not the Holy Grail in the quest for the ideal oestrogen therapy
por: Bińkowska, Małgorzata, et al.
Publicado: (2023) -
Exposure to 17β-Oestradiol Induces Oxidative Stress in the Non-Oestrogen Receptor Invertebrate Species Eisenia fetida
por: Heger, Zbynek, et al.
Publicado: (2015) -
Oestrogen receptor status and the response of human breast cancer cell lines to a combination of methotrexate and 17-beta oestradiol.
por: Clarke, R., et al.
Publicado: (1985) -
Oestradiol-17β plasma concentrations after intramuscular injection of oestradiol benzoate or oestradiol cypionate in llamas (Lama glama)
por: Cavilla, María V, et al.
Publicado: (2010) -
Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor.
por: Levenson, A. S., et al.
Publicado: (1998)